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Stability study of thymoquinone, carvacrol and thymol 
using HPLC-UV and LC-ESI-MS
The aim of this study was to investigate the stability of 
three major antioxidants of Nigella sativa: thymoquinone 
(TQ), carvacrol (CR) and thymol (THY), under different 
stress conditions using HPLC and LC-MS/MS. Forced 
degradation for each compound was performed under 
different conditions, including oxidation, hydrolysis, 
photolysis and thermal decomposition. The results 
showed that both CR and THY were stable under the 
studied conditions, whereas TQ was not affected by acidic, 
basic and oxidative forced conditions but the effect of 
light and heat was significant. The degradation products 
of TQ were further investigated and characterized by 
LC-MS/MS. HPLC-UV method has been fully validated 
in terms of linearity and range, the limit of detection and 
quantitation, precision, selectivity, accuracy and robust-
ness. The method was successfully applied to quantita-
tive analysis of the principal antioxidants of Nigella sativa 
TQ, CR and THY in different phytopharmaceuticals.





Black seed (Nigella sativa, family Ranunculaceae) (NS) is a valuable medicinal plant that 
exhibits several biological activities, including anti-cancer, anti-microbial, anti-inflamma-
tory, anti-atherogenic and cardioprotective (1–3), as well as antioxidant properties (4–6). 
Oxidative stress is generated due to a disturbance in the balance between the production 
of free radicals and the endogenous antioxidants. It plays a crucial role in the pathology of 
various conditions, including aging, cancer and neurodegenerative disorders (7–9). Natu-
ral antioxidants with protective activity against oxidative stress and cellular damage have 
gained much interest.
NS seeds contain a variety of constituents, mainly oils. Thymoquinone (TQ) (2-isopro-
pyl-5-methyl-1,4-benzoquinone) is the major active constituent in the volatile oil (2). The 
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therapeutic value of TQ could be attributed to its antioxidant effects. In comparison with 
TQ, carvacrol (CR) (5-isopropyl-2-methylphenol) and its isomer, thymol (THY) (2-isopro-
pyl-5-methylphenol), are found in lower amounts in the volatile oil as phenolic antioxi-
dants. They are both considered promising compounds (10, 11). 
The quality of phytopharmaceuticals is essential for consumer safety. Improper stor-
age of phytopharmaceuticals may lead to the degradation of products. The presence of 
these degraded products may have a significant negative effect on phytopharmaceuticals 
quality, efficacy and integrity. This occurs through changing the chemical, toxicological 
and pharmacological properties of the active constituents. Thus, maintaining the stability 
of phytoconstituents confirms the delivery of the proper therapeutic doses to consumers. 
Through the literature, several analytical methods have been described for the analysis 
of TQ alone or in combination with THY including HPLC (12–15), UPLC (16), TLC (17) and 
HPTLC (18). CR and THY were analyzed using differential pulse voltammetry (19). Few 
GC methods were used for the estimation of active constituents in NS (4, 20).
Although there are various analytical reports for qualitative and quantitative analysis 
of NS active constituents, only two research papers were reported on the stability-indicat-
ing method for TQ (16, 21), using UPLC for the determination of TQ in formulation or in 
biomatrices such as plasma/serum. The two published methods (16, 21) stated that TQ 
degrades under different forced conditions. However, these methods (16, 21) did not iden-
tify any degradation products of TQ and did not study the stability of other components 
(CR, THY).
The goal of the current research was to investigate the stability of the principal anti-
oxidants of NS (TQ, CR and THY) by using the HPLC technique, and to investigate and 
characterize the degradation products using LC-MS/MS.
EXPERIMENTAL
Materials and reagents
Authentic standards of TQ, CR and THY were obtained from Merck KgaA (Germany) 
and purity of ≥ 99.0, ≥ 98.0 and ≥ 99.0 %, resp., was certified for each standard. Methanol 
(HPLC grade) was purchased from Carlo Erba Reactifs-SDS SAS (France). Formic acid (99 
%) was provided by Carlo Erba (Italy). Sodium hydroxide, 30 % hydrogen peroxide and 
hydrochloric acid of analytical grade were all purchased from Merck.
Baraka® soft gelatin capsules, three different batches (Batch no 412, 418, 422) used, 
were manufactured by TechnoPharma Egypt, Egypt, and packed by Pharco Pharmaceuti-
cals, Egypt. Each capsule was labeled to contain 450 mg of NS seed oil. Black seed® oil used 
was manufactured by El Hawag, Egypt (company for row oils), and Black cumin® oil used 
was manufactured by Zamzam, Egypt (company for extracting natural oils, herbs and 
cosmetics). Each bottle contains 25 mL of Nigella sativa oil.
Analytical methods
The amounts of TQ, CR and THY were quantified using the HPLC-UV apparatus 
(Hitachi LaChrom Elite, Japan) consisting of EZChrom Elite software package, two L-2130 
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pumps, autosampler L-2200, column oven L-2300 and UV–Visible detector, model L-2420. 
The separation was done on a C18 column (Inertsil ODS-3v, 250 mm × 4.6 mm i.d., 5-μm 
particle diameter, GL Sciences, Japan). The mobile phase contained 0.1 % aqueous formic 
acid and methanol, 40:60 (V/V). Twenty microliters of each sample were injected at a flow 
rate of 1.5 mL min–1. The temperature was adjusted to 25 °C and the detection wavelength 
was fixed to 254 nm.
In order to analyze the degraded samples of TQ, CR and THY LC-ESI-MS system in-
corporating an HP 1100 Series HPLC instrument (Agilent Technologies, Germany) and a 
Finnigan LCQ ADVANTAGE MAX mass spectrometer coupled with ESI source (Thermo 
Fisher Scientific, USA), controlled by Xcalibur 1.4 software was used. Chromatographic 
separation was made on a YMCTM ODS-AQ 2 × 150 mm C18 column (Waters, USA). Mass 
spectra were acquired by electrospray ionization in positive mode mass spectrometry 
(ESI/MS) in the mass/charge ratio (m/z) range of 50–1000 during the complete chromato-
graphic run. An injection of 20 μL was used and the source voltage was 4.5 kV, source 
current 100 μA, capillary voltage 3 V and capillary temperature 200 °C, were adjusted for 
optimal detection.
Using LC-ESI-MS, the degradation products were identified by comparing sample 
chromatograms at different degradation times to those of the standard prior to degrada-
tion. Detection of new peaks in the sample chromatograms obtained after degradation 
times is an indication of degradation products.
Standard solutions preparation
Stock standard solutions were prepared by dissolving 10.0 mg TQ, CR and THY, sepa-
rately, in 10 mL of methanol. The standard solutions of 100 μg mL–1 were obtained by  serial 
dilutions of the stock with methanol.
Forced degradation conditions
To develop the forced degradation assays, the following conditions were applied to 
the standard solutions.
Hydrolytic conditions: acid/base-induced degradation. – The degradation was carried out 
by putting 2 mL of the solution containing 100 μg mL–1 of each compound separately in a 
10-mL volumetric flask covered with aluminum foil to exclude the effect of light. The solu-
tion was treated with 2 mL 2 mol L–1 HCl or 2 mL 1 mol L–1 NaOH, resp. The flasks were 
sealed and placed at room temperature for a month. Later, the solutions were neutralized 
as needed (with 2 mol L–1 NaOH or 1 mol L–1 HCl). The final volume was made up with 
mobile phase. In the end, the solutions were filtered by using a 0.45-μm syringe filter and 
injected into the HPLC system. The study was carried out in triplicate.
Oxidative conditions: hydrogen peroxide-induced degradation. – The degradation was per-
formed by pipetting 2 mL of a 100 μg mL–1 solution of each compound, separately, in 10-mL 
volumetric flask covered with aluminum foil. The solution was treated with 0.5 mL of 
hydrogen peroxide solution (30 %, V/V). The flasks were closed and stored at room tem-
perature for a month. Before injecting the solution into the chromatographic system, the 
volume was completed with the mobile phase and filtered using a 0.45-μm syringe filter.
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Photodegradation studies. – The degradation was carried out by pipetting 2 mL of each 
compound (100 μg mL–1) into a 10-mL transparent volumetric flask and completing the 
volume with methanol. The flasks were exposed to direct sunlight for 6 h. Then, the solu-
tions were filtered through a 0.45-μm syringe filter and further injected into the chromato-
graphic system. The experiment was carried out in triplicate.
Thermal degradation. – The thermal decomposition was performed by pipetting 2 mL 
of each compound (100 μg mL–1) in a 10-mL volumetric flask coated with aluminum foil 
and completed to volume with methanol. The flasks were heated to 85 °C for 2 h and fil-
tered using a 0.45-μm syringe filter, before injecting the solution into the chromatographic 
system. The degradation studies were also carried out in triplicate.
Method validation
Validation of the proposed HPLC-UV method was performed with respect to linearity 
concentration range, limits of detection and quantitation, selectivity, precision, accuracy 
and robustness, as per the guidelines of ICH (22).
Linearity and range. – The linearity of the developed HPLC-UV method was judged by 
analyzing seven concentrations in the range 0.4–500 μg mL–1 for TQ and 0.1–100 μg mL–1 
for each CR and THY. Each concentration was prepared three times. The analysis was done 
according to the previous conditions. The linearity was evaluated by plotting peak area 
measured at 254 nm against corresponding concentrations of each drug.
Selectivity. – The selectivity of the HPLC-UV method was achieved with analyses of 
different laboratory prepared mixtures of TQ, CR, and THY within the linearity range, 
spiked with different levels of light and heat degradation products of TQ.
Precision. – For 1.0, 50.0 and 100 μg mL–1 of each compound, the analysis procedure 
previously described under experimental conditions, was repeated three times within a 
day to determine the repeatability (intra-day precision) and three times on different days 
to determine the intermediate precision (inter-day precision) of the method. The relative 
standard deviation (RSD) values for TQ, CR and THY for intra-day and inter-day precision 
were calculated. 
Detection and quantitation limit. – Limit of detection (LOD) and limit of quantification 
(LOQ) were calculated according to the current ICH guidelines (22) as the ratio of 3.3 and 
10 standard deviations of the blank (n = 7), resp., and the slope of the calibration line (14). 
Accuracy. – The accuracy of the HPLC-UV method was tested by adding known 
amounts of the studied compounds to a known concentration of the commercial products 
that were previously analyzed by the proposed method (standard addition method). The 
resulting mixtures were analyzed and the mean percentage recoveries and their standard 
deviations for three replicates were calculated.
Robustness. – The robustness of the method was tested by variation of the organic 
strength of the mobile phase by ± 2 % and the mobile phase flow rate by ± 0.2 %. The effect 
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of these factors on percent recovery of 10 μg mL–1, retention time and resolution of the 
studied compounds was measured. All measurements were done in triplicates.
Sample preparation
The content of twenty capsules from each capsule formulation was weighed and 
mixed. A portion equivalent to the mass of one capsule was accurately weighed, dissolved 
and diluted to 5 mL with methanol. For oil preparations, 0.2 mL oil was transferred into a 
10-mL volumetric flask separately and the volume was completed with methanol. Finally, 
sample solutions were filtered and diluted with the mobile phase to reach the calibration 
range. The calibration procedure described above was followed and the concentration of 
each compound was calculated.
RESULTS AND DISCUSSION
HPLC-UV optimization
The chromatographic conditions of the HPLC-UV method were studied and opti-
mized as a function of methanol concentration in the mobile phase. The chosen chro-
matographic conditions gave good separation of the studied compounds. The optimum 
conditions for the separation were obtained using a C18 column at 25 °C and mobile phase 
composed of 0.1 % formic acid in water and methanol, in the ratio 40:60 (V/V). Using mo-
bile phase containing methanol in a ratio higher than 60 % caused the overlap between 
CR and THY peaks. When trying mobile phase containing methanol, less than 40 % 
separation was achieved but with increased retention time and peak tailing for TQ, CR 
and THY.
The optimized method can be utilized for the analysis of TQ, CR, THY and TQ degra-
dation products. Chromatographic parameters of the optimized HPLC-UV method are 
given in Table I.
Table I. Chromatographic parameters of the optimized HPLC-UV method









TQD1 3.41 2.92 1.87 90,456 0.98
TQD2 3.83 3.40 2.54 97,213 1.06
TQD3 6.40 6.36 3.10 100,567 1.12
TQD4 9.66 10.10 2.97 105,608 1.03
TQ 13.14 14.10 8.53 122,315 1.14
CR 20.20 22.21 1.51 131,334 1.07
THY 21.10 23.25 – 150,446 1.13
a Per meter.
330




 Linearity and range. – The linearity of the calibration curves was confirmed by the high 
value of correlation coefficient of the regression line of 0.9999 for TQ, CR and THY (Table II). 
Selectivity. – using the HPLC-UV method. These data show that the results were unaf-
fected by the presence of the TQ-degradation products (Table III). The obtained chromato-
gram from the laboratory prepared mixtures (Fig. 1) did not show any interference of TQ 
Table II. Characteristic parameters for the regression equations of the proposed HPLC method for determina-
tion of TQ, CR and THY
Parameter TQ CR THY
Linearity range (μg mL–1) 0.4–500 0.1–100 0.1–100
LOD (μg mL–1) 0.006 0.006 0.027





3.15 × 105 7.10 × 103 6.26 × 103
Standard deviation of the slope (Sb) 1.89 × 102 5.21 × 10–1 6.13 × 10–1
Intercept (a) –3.11 × 103 2.78 × 103 1.51 × 104
Correlation coefficient (R) 0.9999 0.9999 0.9999
a Y = a + bγ, where γ is the concentration in μg mL–1 and Y is the peak area, n = 7.
Table III. Model recovery of TQ, CR and THY in laboratory prepared mixtures using the proposed HPLC-UV 
method
  Recovery (%) Concentration (μg mL–1)Mixture










a n = 7
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Fig. 1. HPLC chromatogram of 20-μL injection of laboratory prepared mixture of TQ, CR, THY and 
TQ degradants.
Table IV. Intra- and inter-day model validation of the proposed HPLC-UV method through the  recovery of 




        Intra-day precision    Inter-day precision
Recovery (%)a RSD (%) Recovery (%)a RSD (%)
TQ
1.0 100.2 ± 0.6 0.6 99.7 ± 1.1 1.1
50.0 99.8 ± 0.5 0.5 100.1 ± 0.8 0.8
100.0 100.0 ± 0.4 0.4 100.1 ± 0.7 0.7
CR
1.0 99.9 ± 0.7 0.7 99.7 ± 1.0 1.0
50.0 97.6 ± 0.1 0.1 100.1 ± 0.8 0.8
100.0 100.0 ± 0.4 0.4 100.1 ± 0.7 0.7
THY 
1.0 103.2 ± 0.3 0.3 99.9 ± 0.1 0.1
50.0 99.9 ± 0.6 0.6 99.9 ± 0.9 0. 9
100.0 100.0 ± 0.4 0.4 100.1 ± 0.8 0.8
a Mean ± SD for five determinations.
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degradation products and the three studied compounds. In addition, selectivity was also 
verified by observing the obtained chromatograms from real samples (Fig. 2) and they 
show good resolution between TQ, CR, and THY peaks and the other components or exci-
pients present in the herbal matrix.
Precision. – RSD values as shown in Table IV for TQ, CR and THY, were 0.3–0.7 % for 
repeatability and 0.1–1.1 % for intermediate precision, resp., indicating reasonable preci-
sion of the HPLC-UV method.
Detection and quantitation limits. – The limits of detection and quantification were found 
to be 0.006 and 0.018 μg mL–1 for both TQ and CR, as well as 0.027 and 0.081 μg mL–1 for 
THY (Table II). 
Fig. 2. Typical HPLC chromatograms of 20 μL injection of: a) Baraka® capsules, b) Black seed® oil, c) 
Black cumin® oil phytopharmaceuticals.
a)                                                                b)
                                    c)
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Table V. Application of the standard addition technique to the analysis of TQ, CR and THY on: a) Baraka® 
capsules, b) Black seed® oil, c) Black cumin® oil by the proposed LC-UV method
a) Analyzed conc. (μg mL–1) Added conc. (μg mL–1) Recovery of added analyte (%)
Exp. No. TQ CR THY TQ CR THY TQ CR THY
1 45.0 4.0 1.0 40.0 15.0 20.0 97.8 98.9 99.2
2 20.0 9.0 6.0 10.0 1.0 2.0 98.3 99.6 100.1
3 25.0 6.0 3.0 15.0 10.0 25.0 100.0 100.5 99.3
4 2.0 25.0 5.0 1.0 1.0 20.0 98.0 99.0 100.7
5 60.0 10.0 4.0 3.0 3.0 6.0 97.9 99.9 100.8
6 40.0 15.0 3.0 20.0 2.0 4.0 98.9 100.0 99.5
Mean 98.5 99.7 99.9
SD 0.8 0.6 0.7
b) Analyzed conc. (μg mL–1) Added conc. (μg mL–1) Recovery of added analyte (%)
Exp. No. TQ CR THY TQ CR THY TQ CR THY
1 120.0 77.0 4.4 2.0 4.0 20.0 99.8 99.6 100.6
2 60.0 3.0 15.0 9.0 10.0 6.0 99.5 99.4 100.2
3 35.0 6.5 4.0 6.0 10.0 30.0 99.1 99.7 99.7
4 55.0 4.0 10.0 25.0 1.0 15.0 100.3 99.6 99.5
5 40.0 3.0 3.0 10.0 3.0 40.0 100.6 100.2 99.6
6 30.0 5.0 4.0 15.0 2.0 3.0 100.1 100.3 99.3
Mean 99.9 99.8 99.8
SD 0.6 0.4 0.5
c) Analyzed conc. (μg mL–1) Added conc. (μg mL–1) Recovery of added analyte (%)
Exp. No. TQ CR THY TQ CR THY TQ CR THY
1 100.0 15.0 30.0 4.0 40.0 30.0 100.3 100.3 99.8
2 10.0 1.0 10.0 10.0 10.0 15.0 99.7 99.4 99.7
3 20.0 10.0 25.0 20.0 20.0 20.0 98.9 99.8 100.9
4 30.0 10.0 45.0 30.0 30.0 5.0 100.2 100.8 101.2
5 50.0 20.0 5.0 40.0 8.0 7.0 100 101.2 100.5
6 5.0 20.0 1.0 55.0 6.0 10.0 100.5 99.6 101.1
Mean 99.9 100.2 100.5
SD 0.6 0.7 0.7
n = 6.
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Fig. 3. HPLC chromatograms of 20-μL injection of: a) acid, b) base, c) oxidative, d) light and e) ther-
mally induced forced degradation of CR and THY.
a)                                                                            a)
b)                                                                            b)
c)                                                                            c)
d)                                                                            d)
e)                                                                            e)
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Accuracy. – According to the obtained results (Tables IV and V) a good accuracy was 
observed for this method. Satisfactory, mean percentage recoveries were obtained for 
appli cation of the standard addition technique to the analysis of TQ, CR and THY, respec-
tively, and the results obtained were as follow, 98.5, 99.7, 99.9 % for standard addition on 
Baraka® capsules, 99.9, 99.8, 99.8 % for standard addition on Black seed® oil and 99.9, 100.2, 
100.5 % for standard addition on Black cumin® oil.
Robustness. – Robustness of the method was judged from the obtained results, it was 
concluded that the studied factors did not affect percent recovery of 10 μg mL–1, retention 
time and resolution of the studied compounds (Table VI).
Sample analysis
The proposed HPLC-UV method was applied to the quantification of principal antioxi-
dants in three NS commercial phytopharmaceuticals without the interference of other active 
components present in NS. One batch of Baraka® capsules and one batch of Black seed® oil 
and Black cumin® oil were selected. Every batch was analyzed in triplicate (Table VII). The 
results of the analysed samples were obtained by the developed HPLC-UV method and were 
statistically compared to the published HPLC method (15), using Student’s t-test and the F-
ratio test at 95 % confidence level (Table VII). It is obvious that there is no significant differ-
ence between the performances of the developed and the reported method (15).
Identification of the degradation products by LC-ESI-MS
CR and THY were stable under the studied stress conditions (previously described in 
experimental section) since no new peaks developed (Fig. 3).
TQ was not affected by acidic, basic and oxidative forced conditions, but the effects of 
light and heat were significant (Fig. 4). Under light and thermal stress conditions, TQ (re-
tention time 13.14 min) was degraded to give TQD1, TQD2, TQD3 and TQD4 peaks at 3.41, 
3.83, 6.40 and 9.66 min, resp. These results are in contradiction to the data reported by 
Pathan et al. (16) who stated that TQ degraded in acidic, basic, oxidation and under UV light 
stress conditions.
TQ is sensitive to heat and light; Smith and Tess (23) stated that after exposure to light 
for five days, TQ converted gradually to dithymoquinone (70–80 %), which undergoes redox 
cycling reaction to give other degradation products. 
TQ degraded sample was analyzed by LC-MS/MS. The standard solution of TQ was 
directly injected in the positive ion scan mode in the ESI source. TQ gave protonated mole-
cular ion at m/z 165.46 (M+H)+ and also fragmental ions at m/z 150.33, 148.37, 136.92 and 
122.04, attributed to the loss of a methyl group (m/z 15), hydroxyl group (m/z 17), carbon 
monoxide (m/z 28) and isopropyl (m/z 43), resp. Also, TQ gave a peak at m/z 107.13 which is 
due to the loss of (CH3)2CO plus the radical hydrogen (Fig. 5).
The fragmentation patterns obtained in the mass spectra were used for the characteri-
zation of the parent compound and its degradation products. The degradation product 
TQD1 gave molecular ion at m/z 109.09 (M+H)+, pointing out that it has a molecular mass of 
108.09. TQD1 had a fragment ion at m/z 81.97 attributed to the liberation of carbon monoxide. 
This finding suggested that TQD1 was benzoquinone (Fig. 6). The degradation product 
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TQD2 exhibited molecular ion at m/z 111.11 (M+H)+ corresponding to the molar mass of 
110.11. TQD2 had a fragment ion at m/z 94.02 attributed to the liberation of hydroxyl group. 
This finding suggested that TQD2 was hydroquinone (Fig. 7). The degradation product 
TQD3 exhibited an (M+H)+ ion at m/z 329.96, suggesting that two TQ molecules are linked 
together generating a dimer of TQ. This degradation product was found to be the major 
compound among the analyzed degradation products. This finding suggested that the 
Fig. 4. HPLC chromatograms of 20-μL injection of: a) acid, b) base, c) oxidative, d) thermal and e) 
light-induced forced degradation of TQ.
a)                                                                              b)
c)                                                                             d)
                                        e)
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Fig. 5. MS/MS product ion spectrum of TQ standard after direct injection in the (+) ESI source.
Fig. 6. Product ion mass spectrum of (M+H)+ ions of TQD1.
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Fig. 7. Product ion mass spectrum of (M+H)+ ions of TQD2.
Fig. 8. Product ion mass spectrum of (M+H)+ ions of TQD3.
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degradation product was dithymoquinone (Fig. 8). The degradation product TQD4 in-
volved an (M+H)+ ion at m/z 167.21, so, it has a molecular mass of 166.21. TQD4 had a frag-
ment ion at m/z 152.21 referring to the loss of methyl group. In addition, low-intensity 
peaks appeared at m/z 124.04 and 43.10, indicating the loss of the isopropyl group as well 
Table VIII. Comparison of chromatographic methods for thymoquinone, carvacrol and thymol assay
Method used Analyzed compound Stability studies Reference
HPLC-UV/
LC-ESI-TOF TQ and THY No stability studies 13
HPLC-UV TQ and THY No stability studies 14
HPLC-UV TQ , CR and THY No stability studies 15
HPLC-UV TQ Study stability of TQ only; no identification degradation products 16
TLC TQ No stability studies 17
HPTLC TQ No stability studies 18
GC_MS TQ and CR No stability studies 20
UPLC TQ Study stability of TQ only; no identification degradation products 21
HPLC-UV/
LC-ESI-MS TQ , CR and THY




Fig. 9. Product ion mass spectrum of (M+H)+ ions of TQD4.
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as the formation of isopropyl cation, resp. As seen from Fig. 9 the TQD4 was elucidated to 
be thymohydroquinone. 
A detailed comparison between the developed methods and the published ones is 
given in Table VIII. It is clear that chromatographic methods in refs. 13–15 and 17–20 did 
not study the stability of TQ, CR or THY, whereas only two methods in refs. 16 and 21 
studied the stability of TQ only but did not identify its degradations products. To the best 
of our knowledge, the proposed method is the only method that investigates the stability 
of three principal antioxidants of NS (TQ, CR and THY) by using HPLC technique and 
characterize the degradation products of TQ using LC-MS/MS.
CONCLUSIONS
A study of the behavior of TQ, CR and THY under different stress conditions was 
established. The developed HPLC-UV method is simple, accurate, precise and selective for 
determination of TQ, CR and THY in pure form or in commercial preparations without 
interference from other constituents/excipients/degradants present. The LC-ESI-MS was 
used to confirm the structure and mass of the degradants of TQ. The method proved to be 
simple and selective for giving a distinct separation and identification of TQ and its de-
gradants when exposed to forced degradation conditions. 
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